Levetiracetam
- 1 January 2013
- journal article
- Published by Springer Publishing Company in Neonatal Network
- Vol. 32 (4) , 285-288
Abstract
The incidence of neonatal seizures varies according to gestational age, weight, and cause. Seizures occur in an estimated 1.0-3.5 per 1,000 term infants1 with an increased incidence of 10-130/1,000 in preterm infants.2 Most neonatal seizures have a specific cause.3 Hypoxic-ischemic encephalopathy has been identified as the most common etiology associated with neonatal seizures, accounting for 50-60 percent of the cases.4 Table 1 outlines common causes of neonatal seizures. Early recognition of seizures and appropriate treatment is vital in preventing multiorgan dysfunction and permanent brain damage.Keywords
This publication has 19 references indexed in Scilit:
- Neonatal SeizuresNeoReviews, 2012
- The efficacy and side effects of levetiracetam on refractory epilepsy in childrenJournal of Pediatric Neurosciences, 2012
- Levetiracetam in the treatment of neonatal seizures: A pilot studySeizure: European Journal of Epilepsy, 2010
- Neonatal SeizuresPediatrics in Review, 2010
- Neonatal Seizures: An Update on Mechanisms and ManagementClinics in Perinatology, 2009
- Controversies in Neonatal Seizure ManagementJournal of Child Neurology, 2009
- Neonatal seizuresAnnals of Neurology, 2007
- Synaptic Vesicle Protein 2 Enhances Release Probability at Quiescent SynapsesThe Journal of Neuroscience, 2006
- Pharmacology ReviewNeoReviews, 2004
- Pharmacokinetics of LevetiracetamEpilepsia, 2001